Dates: 01/06/2018
31/05/2023
Topic: Biomarkers identification
Procedures
Project type: Preclinic
Clinic
Project target: Neurology
Financing:
H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being MAIN PROGRAMME
H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2)
Other
Participating agents:
KING’S COLLEGE LONDON
Keywords: Autism Spectrum Disorder; clinical trial; biomarker; procedures; network; consortium
Countries: UK; Switzerland; Netherlands; Spain; France; Germany; Belgium; France; Ireland; Sweden; Italy; South Africa; Portugal; Israel; USA
Project page: Access page
